IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 21 filers reported holding IO BIOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,837,119 | -29.6% | 2,055,883 | 0.0% | 0.04% | -20.0% |
Q2 2023 | $4,029,531 | +4.8% | 2,055,883 | 0.0% | 0.06% | -3.5% |
Q1 2023 | $3,844,501 | -18.7% | 2,055,883 | 0.0% | 0.06% | -19.7% |
Q4 2022 | $4,728,531 | -15.1% | 2,055,883 | 0.0% | 0.07% | -31.1% |
Q3 2022 | $5,571,000 | -42.0% | 2,055,883 | 0.0% | 0.10% | -45.8% |
Q2 2022 | $9,601,000 | +0.2% | 2,055,883 | 0.0% | 0.19% | +8.6% |
Q1 2022 | $9,580,000 | -6.5% | 2,055,883 | 0.0% | 0.18% | +0.6% |
Q4 2021 | $10,243,000 | – | 2,055,883 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,120,437 | $7,171,000 | 1.39% |
Vivo Capital, LLC | 3,015,545 | $19,299,000 | 1.16% |
Novo Holdings A/S | 3,277,932 | $20,979,000 | 0.99% |
Soleus Capital Management, L.P. | 672,734 | $4,305,000 | 0.43% |
PFM Health Sciences, LP | 1,362,144 | $7,744,000 | 0.26% |
RA Capital Management | 1,857,755 | $11,890,000 | 0.21% |
Avoro Capital Advisors LLC | 2,055,883 | $10,243,000 | 0.17% |
Virtu Financial LLC | 12,665 | $83,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 50,479 | $323,000 | 0.01% |
Capital World Investors | 1,235,000 | $8,114,000 | 0.00% |